<< Press Ganey releases report on home care patient satisfaction | New journal focuses on therapeutic hypothermia and its applications in cardiology and neurotrauma >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | العربية | Nederlands | Finnish | Русский | Svenska | Polski

Analysis of DNA and RNA at the molecular level

Published on October 12, 2009 at 6:48 AM · No Comments

Reportlinker.com announces that a new market research report is available in its catalogue: Molecular Diagnostics Market: Trends and Opportunities

http://www.reportlinker.com/p0132730/Molecular-Diagnostics-Market-Trends-and-Opportunities.html

Molecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing market, driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics (IVD) market, molecular diagnostics market is one of the two growth drivers of the IVD industry.

In the decision making process of healthcare experts, diagnostics tests have a major influence. Diagnostics tests are a very small percentage cost of medical expenditures but generally accounts for 60-70% of all treatment decisions. And with the advent of molecular diagnostics, there is a growing focus on diagnostics for early detection of diseases.

Molecular diagnostics holds immense business potential as it is based on the intention of identifying viruses and infectious diseases more accurately at an earlier stage than currently possible. Molecular diagnostics has also emerged as a potential business opportunity as diagnostics businesses generally fetch higher returns of investment than pharmaceutical and other biotech businesses.

The molecular diagnostics industry is growing on the path of continuous innovation and changing technological base and this is creating new opportunities and applications. The major factors that will drive the growth of this industry includes the increasing incidences of various chronic diseases, increasing number of cases of hepatitis B and tuberculosis and the availability of various molecular diagnostics tests. Molecular diagnostics or MDx is the fastest growing segment of the IVD market, also because of the innovation in the industry resulting in the advent of new technologies for genetic testing, faster screening and more precise detection.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading